SavedAdd your journal

Journals / Recent Trends in Pharmacology / 2023 / Cilt: 1 Sayı: 1

Pyrogallol Induces Selective Cytotoxicity in SH-SY5Y and Cortical Neuron Cells

Betul CİCEK
Ali.tgzd TGZD
Betül ÇİÇEK
Esra ŞENTÜRK
Mustafa GÜL
Fatma YESİLYURT
Ahmet HACIMÜFTÜOĞLU
Pages
1–10
Publication Date
2023-04-30
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

However, having a cytotoxic effect in lower concentrations of PG without decreasing antioxidant enzyme activities suggests that PG may have alternative mechanisms for cytotoxicity in lower concentrations.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: We aimed to evaluate whether pyrogallol (PG) has selective cytotoxic effects on neuroblastoma (SH-SY5Y) cells and cortical neuronal cells.
📊
Key Findings & Data:Materials and Methods: SH-SY5Y cells and cortical neuronal cells were treated with PG at different concentrations for 24 h.
💡
Conclusion & Impact:However, having a cytotoxic effect in lower concentrations of PG without decreasing antioxidant enzyme activities suggests that PG may have alternative mechanisms for cytotoxicity in lower concentrations.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:polyphenolic compound · pyrogallol · SH-SY5Y

Abstract

Objective: We aimed to evaluate whether pyrogallol (PG) has selective cytotoxic effects on neuroblastoma (SH-SY5Y) cells and cortical neuronal cells. Materials and Methods: SH-SY5Y cells and cortical neuronal cells were treated with PG at different concentrations for 24 h. Cytotoxicity was assessed by MTT test. Catalase (CAT), glutathione reductase (GR) activities, and glutathione (GSH) levels were also quantified. Results: Treatment of neuroblastoma cells with PG (20–200 μM) significantly decreased cell viability. It had no effect on the cell viability of cortical neuronal cells at 20-80 μM. However, it decreased the viability in cortical neuronal cells at 200 μM. CAT, GR, and GSH levels were notably reduced in neuroblastoma cells treated with 200 μM of PG; but, only GSH was reduced in cortical neuronal cells at this concentration. Conclusion: PG had a specific cytotoxic effect in neuroblastoma cells but generally spared neuronal cells. PG decreased the antioxidant enzyme activities in neuroblastoma cells suggesting that it kills cancer cells by causing increased oxidative stress. However, having a cytotoxic effect in lower concentrations of PG without decreasing antioxidant enzyme activities suggests that PG may have alternative mechanisms for cytotoxicity in lower concentrations.

🔖

Cite This Article

CİCEK, B., TGZD, A., ÇİÇEK, B., ŞENTÜRK, E., GÜL, M., YESİLYURT, F., HACIMÜFTÜOĞLU, A. (2023). Pyrogallol Induces Selective Cytotoxicity in SH-SY5Y and Cortical Neuron Cells. Recent Trends in Pharmacology, Cilt: 1 Sayı: 1, 1–10. https://ajindex.com/articles/1016088

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Ahn, H., Im, E., Lee, D. Y., Lee, H.-J., Jung, J. H., & Kim, S.-H. (2019). Antitumor effect of Pyrogallol via miR-134 mediated S phase arrest and inhibition of PI3K/AKT/Skp2/cMyc signaling in hepatocellular carcinoma. International journal of molecular sciences, 20(16), 3985. Atanasov, A. G., Zotchev, S. B., Dirsch, V. M., & Supuran, C. T. (2021). Natural products in drug discovery: Advances and opportunities. Nature Reviews Drug Discovery, 20(3), 200-216.
  2. Bardaweel, S. K., Gul, M., Alzweiri, M., Ishaqat, A., ALSalamat, H. A., & Bashatwah, R. M. (2018). Reactive oxygen species: The dual role in physiological and pathological conditions of the human body. The Eurasian journal of medicine, 50(3), 193. Bhoopathi, P., Mannangatti, P., Emdad, L., Das, S. K., & Fisher, P. B. (2021). The quest to develop an effective therapy for neuroblastoma. Journal of Cellular Physiology, 236(11), 7775-7791.
  3. Blagosklonny, M. (2005). Carcinogenesis, cancer therapy and chemoprevention. Cell Death & Differentiation, 12(6), 592-602.
  4. Bradford, M. M. (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analytical biochemistry, 72(1-2), 248-254.
  5. Briguglio, G., Costa, C., Pollicino, M., Giambò, F., Catania, S., & Fenga, C. (2020). Polyphenols in cancer prevention: New insights. International Journal of Functional Nutrition, 1(2), 1-1.
  6. Brodeur, G. M. (2018). Spontaneous regression of neuroblastoma. Cell and tissue research, 372(2), 277-286.
  7. Ferah Okkay, I., Okkay, U., Cicek, B., Yilmaz, A., Yesilyurt, F., Mendil, A. S., & Hacimuftuoglu, A. (2021). Neuroprotective effect of bromelain in 6-hydroxydopamine induced in vitro model of Parkinson’s disease. Molecular Biology Reports, 48(12), 7711-7717.
  8. Glasauer, A., & Chandel, N. S. (2014). Targeting antioxidants for cancer therapy. Biochemical pharmacology, 92(1), 90-101.
  9. Habig, W. H., Pabst, M. J., & Jakoby, W. B. (1974). Glutathione S-transferases: the first enzymatic step in mercapturic acid formation. Journal of Biological Chemistry, 249(22), 7130-7139.
  10. Han, Y. H., Kim, S. Z., Kim, S. H., & Park, W. H. (2008). Pyrogallol inhibits the growth of human lung cancer Calu-6 cells via arresting the cell cycle arrest. Toxicology in Vitro, 22(6), 1605-1609.
  11. Hayes, J. D., Dinkova-Kostova, A. T., & Tew, K. D. (2020). Oxidative stress in cancer. Cancer cell. Kim, S. W., Han, Y. W., Lee, S. T., Jeong, H. J., Kim, S. H., Kim, I. H., Kim, S. Z. (2008). A superoxide a